Information
-
Trademark
-
79342589
-
Serial Number
79342589
-
Registration Number
7141339
-
International Classifications
-
Filing Date
February 25, 2022
2 years ago
-
Registration Date
August 22, 2023
a year ago
-
Transaction Date
June 18, 2024
8 months ago
-
Status Date
August 22, 2023
a year ago
-
Published for Opposition Date
June 06, 2023
a year ago
-
Location Date
May 10, 2024
9 months ago
-
Status Code
700
-
Current Location
TMEG LAW OFFICE 104
Employee Name
EISNACH, MICHAEL PATRI
-
Attorney Docket Number
0332004
Attorney Name
M. Scott Alprin
Law Office Assigned Location Code
L40
-
Owners
Mark Drawing Code
5
Mark Identification
ASTARTZ
Case File Statements
- GS0401: Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
- DM0000: The mark consists of the Greek letter "alpha" before the term "STARTZ" appearing as one word in stylized format.
- B00001: In the statement, line 56 and 57, " The mark consists of the Greek letter alpha plus the term "STARTZ" appearing as "aSTARTZ" and pronounced as "alphaSTARTZ," in stylized format." should be deleted, and "The mark consists of the Greek letter "alpha" before the term "STARTZ" appearing as one word in stylized format." should be inserted.
- GS0051: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
- GS0011: Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
- GS0451: Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights
- GS0421: Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances
Case File Event Statements
-
6/16/2022 - 2 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
6/22/2022 - 2 years ago
2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED
Type: LIMI
-
6/23/2022 - 2 years ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
6/28/2022 - 2 years ago
4 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
9/30/2022 - 2 years ago
5 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
12/9/2022 - 2 years ago
6 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/19/2022 - 2 years ago
7 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/20/2022 - 2 years ago
8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
2/15/2023 - 2 years ago
9 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
2/15/2023 - 2 years ago
10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
3/6/2023 - a year ago
11 - REFUSAL PROCESSED BY IB
Type: RFNT
-
4/17/2023 - a year ago
12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/17/2023 - a year ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/18/2023 - a year ago
14 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/19/2023 - a year ago
15 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
4/22/2023 - a year ago
16 - TEAS POST PUBLICATION AMENDMENT RECEIVED
Type: EPPA
-
4/25/2023 - a year ago
17 - WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Type: PBMR
-
4/26/2023 - a year ago
18 - PREVIOUS ALLOWANCE COUNT WITHDRAWN
Type: ZZZX
-
5/1/2023 - a year ago
19 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
5/1/2023 - a year ago
20 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
5/1/2023 - a year ago
21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
5/1/2023 - a year ago
22 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
5/1/2023 - a year ago
23 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/15/2023 - a year ago
24 - ASSIGNED TO PETITION STAFF
Type: APET
-
5/17/2023 - a year ago
25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/17/2023 - a year ago
26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
5/17/2023 - a year ago
27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
6/6/2023 - a year ago
28 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/6/2023 - a year ago
29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/6/2023 - a year ago
30 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Type: CHPB
-
6/6/2023 - a year ago
31 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
8/22/2023 - a year ago
32 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
8/22/2023 - a year ago
33 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
8/28/2023 - a year ago
34 - TEAS SECTION 7 REQUEST RECEIVED
Type: ES7R
-
11/22/2023 - a year ago
35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
11/27/2023 - a year ago
36 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
11/27/2023 - a year ago
37 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
12/19/2023 - a year ago
38 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
5/9/2024 - 9 months ago
39 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
5/10/2024 - 9 months ago
40 - CORRECTION UNDER SECTION 7 - PROCESSED
Type: COC.
-
6/18/2024 - 8 months ago
41 - NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Type: NURC